Emerging drugs and targets for alzheimer's disease.
| Other Authors: | |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Cambridge,
Royal Society of Chemistry,
2010.
|
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1039/9781849731072 |
Table of Contents:
- Neuronal Plasticity as target
- Chapter 15: Regeneration of Degenerated Brain: A Promising Therapeutic Target
- Chapter 16: Promoting synaptic resilience in AD patients through PDE inhibition
- Chapter 17: A new generation of non invasive NGF-based therapies for Alzheimer's disease
- Chapter 18: Possible clinical applications of stem cell strategies in AD therapies
- Neuronal protection as target
- Chapter 19: Targeting Oxidative Mechanisms in Alzheimer Disease
- Chapter 20: Davunetide (NAP) Pharmacology: Neuroprotection and tau
- Chapter 21: Targeting NF- B inflammatory and pro-survival signaling in AD
- Chapter 22: PPAR in Alzheimer's disease
- Miscellaneous targets and strategies
- Chapter 23: Serotonin 5-HT4 receptors as pharmacological targets for the treatment of Alzheimer's disease
- Chapter 24: Liver X Receptors as potential therapeutic target for AD
- Chapter 25: Discovery of memoquin, a multi-target-directed ligand for the treatment of Alzheimer's disease
- Chapter 26: RNA interference of genes related to AD
- Chapter 27: Medicinal plants, phytochemicals and Alzheimer's Disease.